Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Autor:
Zsolt Abonyi-Tóth, Krisztián Horváth, Balázs Nagy, László Urbán, Veronika Sárosi, Krisztina Bogos, Zoltán Polányi, Zoltán Kiss, Judit Moldvay, Zsófia Nagy-Erdei, Nóra Bittner, Lilla Tamási, Andrea Daniel, Gyula Ostoros, Aladár Vastag, György Rokszin, Veronika Müller, Gabriella Gálffy, Zoltán Vokó
Publikováno v:
Pathology and Oncology Research
Background: No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungar
Publikováno v:
Pathology and Oncology Research
Background: The objective was to explore the discordance in the expression of the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 between primary and recurrent/metastatic lesions in patie
Autor:
Roberto Sánchez-Reyes, Luis Cabrera-Miranda, Héctor Aquiles Maldonado-Martínez, Suraj Samtani-Bassarmal, Oscar Arrieta, Graciela Cruz-Rico, Luis Lara-Mejía, Xitlally Popa-Navarro, Rodrigo Catalán, Dennis López-Sánchez, Alejandro Avilés-Salas
Publikováno v:
Pathology and Oncology Research
Background: Programmed cell death-ligand 1 (PD-L1) protein expression is one of the most extensively studied biomarkers in patients with non-small cell lung cancer (NSCLC). However, there is scarce information regarding its association with distinct
Publikováno v:
Pathology and Oncology Research
Background: We evaluated the prognostic value of C-reactive protein/albumin (CAR) and systemic immune-inflammation index (SII), which we calculated as neutrophil × platelet/lymphocyte) in patients with colorectal liver metastasis (CRLM) after curati
Autor:
Divya Nagarajan, Stephen Chan, Catherine Johnson, Simon P. Hood, Gemma A. Foulds, Tarek M. A. Abdel-Fatah, Stephanie E. B. McArdle, Jayakumar Vadakekolathu, Paul M. Moseley, Sergio Rutella, A. Graham Pockley, Stephen Reeder
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Background: Interactions between the immune system and tumors are highly reciprocal in nature, leading to speculation that tumor recurrence or therapeutic resistance could be influenced or predicted by immune events that manifest locally, but can be